About this course
The emphasis of the course is on biomedicine, drug discovery, and development showcased through a focus on the European pharmaceutical and biotech research community. You learn about the general principles of drug discovery and development, including safety, toxicology, formulation, registration, and clinical trials. The course explores the opportunities and challenges biotechnology has for medicine, among them the new types of biotechnological drugs, gene therapy, and personalized medicine.
Syllabus
Pre-requisites
One year each of biology and chemistry at university level.
Faculty
Kim Jacobsen
FacultyMSc (Pharmacy, Copenhagen, 1985), Ph.D. (Biotechnology, Denmark Technical University, 1987), MBA (Sophia University, Tokyo, 1992). International Marketing, Novo Nordisk, 1994-2008. Project VP, Novo Nordisk, 2008-2014. Head of Commercial Haemophilia, Sobi Stockholm, 2014-2017. Head of Commercial Operations, Sobi Brussels/Paris, 2018-2022. Head of Commercial, Zealand Pharma, Copenhagen, 2022-2023. With DIS since 2024.
Jeanette Erbo Wern
Faculty; Senior Research ManagerPostdoc (Inst. of International Health, Immunology and Microbiology, University of Copenhagen, Denmark, 2006-2009). Ph.D. (Immunology, Inst. Of International Health, Immunology and Microbiology, University of Copenhagen, 2005). M.Sc. (Inst. Of International Health, Immunology and Microbiology, University of Copenhagen, 2001). Senior Scientist, Immune Targeting Group, Bioneer, Copenhagen, Denmark, 2010-2013. Senior Scientist, Dept. of Infectious Disease Immunology, Statens Serum Institute, Copenhagen, Denmark, 2013-2016. With DIS since 2016.